{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T08:51:39Z","timestamp":1794905499253,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011318","name":"Fondation Botnar","doi-asserted-by":"publisher","award":["FTC_14052020"],"award-info":[{"award-number":["FTC_14052020"]}],"id":[{"id":"10.13039\/501100011318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["4078P0_198345"],"award-info":[{"award-number":["4078P0_198345"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Growing evidence links COVID-19 with acute and long-term neurological dysfunction. However, the pathophysiological mechanisms resulting in central nervous system involvement remain unclear, posing both diagnostic and therapeutic challenges. Here we show outcomes of a cross-sectional clinical study (NCT04472013) including clinical and imaging data and corresponding multidimensional characterization of immune mediators in the cerebrospinal fluid (CSF) and plasma of patients belonging to different Neuro-COVID severity classes. The most prominent signs of severe Neuro-COVID are blood-brain barrier (BBB) impairment, elevated microglia activation markers and a polyclonal B cell response targeting self-antigens and non-self-antigens. COVID-19 patients show decreased regional brain volumes associating with specific CSF parameters, however, COVID-19 patients characterized by plasma cytokine storm are presenting with a non-inflammatory CSF profile. Post-acute COVID-19 syndrome strongly associates with a distinctive set of CSF and plasma mediators. Collectively, we identify several potentially actionable targets to prevent or intervene with the neurological consequences of SARS-CoV-2 infection.<\/jats:p>","DOI":"10.1038\/s41467-022-34068-0","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T14:11:34Z","timestamp":1668003094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-8305","authenticated-orcid":false,"given":"Manina M.","family":"Etter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-2288","authenticated-orcid":false,"given":"Tom\u00e1s A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5236-8323","authenticated-orcid":false,"given":"Laila","family":"Kulsvehagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6271-2404","authenticated-orcid":false,"given":"Elisabeth","family":"P\u00f6ssnecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandrille","family":"Duchemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretel","family":"Sanabria-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1394-8231","authenticated-orcid":false,"given":"Jannis","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Chiappini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rychen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebmi","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester","family":"Melie-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3090-7319","authenticated-orcid":false,"given":"Ilijas","family":"Jelcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1234-7568","authenticated-orcid":false,"given":"Hans","family":"Pargger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-4140","authenticated-orcid":false,"given":"Martin","family":"Siegemund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Oechtering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2005-5266","authenticated-orcid":false,"given":"Matthias S.","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarp","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcr","family":"Yaldizli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9407-6473","authenticated-orcid":false,"given":"Johanna M.","family":"Lieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios-Nikos","family":"Psychogios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-9356","authenticated-orcid":false,"given":"Karoline","family":"Leuzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Granziera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-1872","authenticated-orcid":false,"given":"Anne-Katrin","family":"Pr\u00f6bstel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7570-3902","authenticated-orcid":false,"given":"Gregor","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"34068_CR1","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.immuni.2021.06.002","volume":"54","author":"M Schwabenland","year":"2021","unstructured":"Schwabenland, M. et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity 54, 1594\u20131610.e11 (2021).","journal-title":"Immunity"},{"key":"34068_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.immuni.2020.12.011","volume":"54","author":"M Heming","year":"2021","unstructured":"Heming, M. et al. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. Immunity 54, 164\u2013175.e6 (2021).","journal-title":"Immunity"},{"key":"34068_CR3","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1212\/WNL.0000000000010979","volume":"96","author":"JA Frontera","year":"2021","unstructured":"Frontera, J. A. et al. A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology 96, e575\u2013e586 (2021).","journal-title":"Neurology"},{"key":"34068_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-020-02213-y","volume":"140","author":"N Deigendesch","year":"2020","unstructured":"Deigendesch, N. et al. Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology. Acta Neuropathologica 140, 583\u2013586 (2020).","journal-title":"Acta Neuropathologica"},{"key":"34068_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","volume":"595","author":"AC Yang","year":"2021","unstructured":"Yang, A. C. et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595, 565\u2013571 (2021).","journal-title":"Nature"},{"key":"34068_CR6","doi-asserted-by":"publisher","first-page":"e957","DOI":"10.1212\/NXI.0000000000000957","volume":"8","author":"V Fuchs","year":"2021","unstructured":"Fuchs, V. et al. Presence of SARS-CoV-2 Transcripts in the Choroid Plexus of MS and Non-MS Patients With COVID-19. Neurology - Neuroimmunology Neuroinflammation 8, e957 (2021).","journal-title":"Neurology - Neuroimmunology Neuroinflammation"},{"key":"34068_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.tins.2021.10.006","volume":"44","author":"AK Pr\u00f6bstel","year":"2021","unstructured":"Pr\u00f6bstel, A. K. et al. SARS-CoV-2-specific neuropathology: fact or fiction? Trends in Neurosciences 44, 933\u2013935 (2021).","journal-title":"Trends in Neurosciences"},{"key":"34068_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","volume":"604","author":"G Douaud","year":"2022","unstructured":"Douaud, G. et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604, 697\u2013707 (2022).","journal-title":"Nature"},{"key":"34068_CR9","doi-asserted-by":"publisher","first-page":"117090","DOI":"10.1016\/j.jns.2020.117090","volume":"418","author":"B Neumann","year":"2020","unstructured":"Neumann, B. et al. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms. J. Neurol. Sci. 418, 117090 (2020).","journal-title":"J. Neurol. Sci."},{"key":"34068_CR10","doi-asserted-by":"publisher","first-page":"e3102","DOI":"10.1093\/cid\/ciaa1165","volume":"73","author":"M Bellon","year":"2021","unstructured":"Bellon, M. et al. Cerebrospinal Fluid Features in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reverse Transcription Polymerase Chain Reaction (RT-PCR) Positive Patients. Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am. 73, e3102\u2013e3105 (2021).","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"key":"34068_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25509-3","volume":"12","author":"SE Chang","year":"2021","unstructured":"Chang, S. E. et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 12, 5417 (2021).","journal-title":"Nat. Commun."},{"key":"34068_CR12","doi-asserted-by":"publisher","first-page":"100288","DOI":"10.1016\/j.xcrm.2021.100288","volume":"2","author":"E Song","year":"2021","unstructured":"Song, E. et al. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep. Med. 2, 100288 (2021).","journal-title":"Cell Rep. Med."},{"key":"34068_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3233\/JAD-200581","volume":"76","author":"M Fotuhi","year":"2020","unstructured":"Fotuhi, M., Mian, A., Meysami, S. & Raji, C. A. Neurobiology of COVID-19. J. Alzheimers Dis. JAD 76, 3\u201319 (2020).","journal-title":"J. Alzheimers Dis. JAD"},{"key":"34068_CR14","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection.","year":"2020","unstructured":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20, e192\u2013e197 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"34068_CR15","doi-asserted-by":"crossref","unstructured":"Chaudhary, N. & Wesemann, D. R. Analyzing Immunoglobulin Repertoires. Front. Immunol. 9, 462 (2018).","DOI":"10.3389\/fimmu.2018.00462"},{"key":"34068_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target. Ther. 6, 255 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"34068_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25191-5","volume":"12","author":"M Perreau","year":"2021","unstructured":"Perreau, M. et al. The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients. Nat. Commun. 12, 4888 (2021).","journal-title":"Nat. Commun."},{"key":"34068_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1398-3","volume":"16","author":"Q Liu","year":"2019","unstructured":"Liu, Q. et al. Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca2+-dependent PKC\/p38MAPK\/NF-\u03baB pathway. J. Neuroinflammation 16, 10 (2019).","journal-title":"J. Neuroinflammation"},{"key":"34068_CR19","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. J. Soc. Neurosci. 32, 6391\u20136410 (2012).","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"34068_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41586-021-03925-1","volume":"598","author":"FA Lempp","year":"2021","unstructured":"Lempp, F. A. et al. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature 598, 342\u2013347 (2021).","journal-title":"Nature"},{"key":"34068_CR21","doi-asserted-by":"publisher","first-page":"651484","DOI":"10.3389\/fcimb.2021.651484","volume":"11","author":"JJ Kovarik","year":"2021","unstructured":"Kovarik, J. J. et al. Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection. Front. Cell. Infect. Microbiol. 11, 651484 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"34068_CR22","doi-asserted-by":"publisher","first-page":"602395","DOI":"10.3389\/fimmu.2020.602395","volume":"11","author":"L Li","year":"2021","unstructured":"Li, L. et al. Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients. Front. Immunol. 11, 602395 (2021).","journal-title":"Front. Immunol."},{"key":"34068_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/mi.2013.47","volume":"7","author":"I Moshkovits","year":"2014","unstructured":"Moshkovits, I. et al. CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis. Mucosal Immunol. 7, 292\u2013303 (2014).","journal-title":"Mucosal Immunol."},{"key":"34068_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/joim.13178","volume":"289","author":"H Hoel","year":"2021","unstructured":"Hoel, H. et al. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. J. Intern. Med. 289, 523\u2013531 (2021).","journal-title":"J. Intern. Med."},{"key":"34068_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41423-020-0484-x","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients. Cell. Mol. Immunol. 17, 878\u2013880 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"34068_CR26","doi-asserted-by":"crossref","unstructured":"Tian, Y. et al. Activation of RAR\u03b1 Receptor Attenuates Neuroinflammation After SAH via Promoting M1-to-M2 Phenotypic Polarization of Microglia and Regulating Mafb\/Msr1\/PI3K-Akt\/NF-\u03baB Pathway. Front. Immunol. 13, 839796 (2022).","DOI":"10.3389\/fimmu.2022.839796"},{"key":"34068_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00004647-199703000-00005","volume":"17","author":"T Kossmann","year":"1997","unstructured":"Kossmann, T. et al. Interleukin-8 Released into the Cerebrospinal Fluid after Brain Injury is Associated with Blood\u2013Brain Barrier Dysfunction and Nerve Growth Factor Production. J. Cereb. Blood Flow. Metab. 17, 280\u2013289 (1997).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"34068_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/01.jnen.0000195943.32786.39","volume":"65","author":"KD Geiger","year":"2006","unstructured":"Geiger, K. D., Stoldt, P., Schlote, W. & Derouiche, A. Ezrin Immunoreactivity Reveals Specific Astrocyte Activation in Cerebral HIV. J. Neuropathol. Exp. Neurol. 65, 87\u201396 (2006).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"34068_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/neu.2014.3517","volume":"32","author":"C L\u00f6\u00f6v","year":"2015","unstructured":"L\u00f6\u00f6v, C., Nadadhur, A. G., Hillered, L., Clausen, F. & Erlandsson, A. Extracellular ezrin: a novel biomarker for traumatic brain injury. J. Neurotrauma 32, 244\u2013251 (2015).","journal-title":"J. Neurotrauma"},{"key":"34068_CR30","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3389\/fimmu.2021.695242","volume":"12","author":"F Sabbatino","year":"2021","unstructured":"Sabbatino, F. et al. PD-L1 Dysregulation in COVID-19 Patients. Front. Immunol. 12, 2198 (2021).","journal-title":"Front. Immunol."},{"key":"34068_CR31","doi-asserted-by":"publisher","first-page":"8734","DOI":"10.1523\/JNEUROSCI.0940-20.2020","volume":"40","author":"SG Dastidar","year":"2020","unstructured":"Dastidar, S. G. et al. 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson\u2019s Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response. J. Neurosci. 40, 8734\u20138745 (2020).","journal-title":"J. Neurosci."},{"key":"34068_CR32","doi-asserted-by":"publisher","first-page":"fcz028","DOI":"10.1093\/braincomms\/fcz028","volume":"1","author":"G Divolis","year":"2019","unstructured":"Divolis, G. et al. Activation of both transforming growth factor-\u03b2 and bone morphogenetic protein signalling pathways upon traumatic brain injury restrains pro-inflammatory and boosts tissue reparatory responses of reactive astrocytes and microglia. Brain Commun. 1, fcz028 (2019).","journal-title":"Brain Commun."},{"key":"34068_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1522-4","volume":"16","author":"JM Ilarregui","year":"2019","unstructured":"Ilarregui, J. M. et al. Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation. J. Neuroinflammation 16, 130 (2019).","journal-title":"J. Neuroinflammation"},{"key":"34068_CR34","doi-asserted-by":"publisher","first-page":"105996","DOI":"10.1016\/j.cmpb.2021.105996","volume":"202","author":"\u015e Ya\u015far","year":"2021","unstructured":"Ya\u015far, \u015e., \u00c7olak, C. & Yolo\u011flu, S. Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling. Comput. Methods Prog. Biomed. 202, 105996 (2021).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"34068_CR35","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","volume":"21","author":"J-Y Zhang","year":"2020","unstructured":"Zhang, J.-Y. et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat. Immunol. 21, 1107\u20131118 (2020).","journal-title":"Nat. Immunol."},{"key":"34068_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","volume":"40","author":"DC Maddison","year":"2015","unstructured":"Maddison, D. C. & Giorgini, F. The kynurenine pathway and neurodegenerative disease. Semin. Cell Dev. Biol. 40, 134\u2013141 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"34068_CR37","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/v13061062","volume":"13","author":"V Callahan","year":"2021","unstructured":"Callahan, V. et al. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner. Viruses 13, 1062 (2021).","journal-title":"Viruses"},{"key":"34068_CR38","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano, J. B. et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102\u2013e107 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"34068_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1159\/000350523","volume":"5","author":"VR Simhadri","year":"2013","unstructured":"Simhadri, V. R., Mariano, J. L., Gil-Krzewska, A., Zhou, Q. & Borrego, F. CD300c is an Activating Receptor Expressed on Human Monocytes. J. Innate Immun. 5, 389\u2013400 (2013).","journal-title":"J. Innate Immun."},{"key":"34068_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","volume":"146","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J. Allergy Clin. Immunol. 146, 119\u2013127.e4 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34068_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41232-017-0037-6","volume":"37","author":"Y Fujita","year":"2017","unstructured":"Fujita, Y. & Yamashita, T. The roles of RGMa-neogenin signaling in inflammation and angiogenesis. Inflamm. Regen. 37, 6 (2017).","journal-title":"Inflamm. Regen."},{"key":"34068_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0348-y","volume":"12","author":"F Guillot","year":"2015","unstructured":"Guillot, F. et al. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation. J. Neuroinflammation 12, 130 (2015).","journal-title":"J. Neuroinflammation"},{"key":"34068_CR43","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.4049\/jimmunol.1002305","volume":"185","author":"TA Jackson","year":"2010","unstructured":"Jackson, T. A., Haga, C. L., Ehrhardt, G. R. A., Davis, R. S. & Cooper, M. D. FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells. J. Immunol. 185, 7405\u20137412 (2010).","journal-title":"J. Immunol."},{"key":"34068_CR44","doi-asserted-by":"crossref","unstructured":"Blank, A. E. et al. Tumour necrosis factor receptor superfamily member 9 (TNFRSF9) is up-regulated in reactive astrocytes in human gliomas. Neuropathol Appl Neurobiol. 41, e56\u201367 (2015).","DOI":"10.1111\/nan.12135"},{"key":"34068_CR45","doi-asserted-by":"publisher","first-page":"590480","DOI":"10.3389\/fneur.2020.590480","volume":"11","author":"A Glasnovi\u0107","year":"2020","unstructured":"Glasnovi\u0107, A., O\u2019Mara, N., Kova\u010di\u0107, N., Gr\u010devi\u0107, D. & Gajovi\u0107, S. RANK\/RANKL\/OPG Signaling in the Brain: A Systematic Review of the Literature. Front. Neurol. 11, 590480 (2020).","journal-title":"Front. Neurol."},{"key":"34068_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35898-z","volume":"8","author":"M Shimamura","year":"2018","unstructured":"Shimamura, M. et al. Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke. Sci. Rep. 8, 17770 (2018).","journal-title":"Sci. Rep."},{"key":"34068_CR47","doi-asserted-by":"publisher","first-page":"e680749","DOI":"10.1155\/2015\/680749","volume":"2015","author":"F Bossi","year":"2015","unstructured":"Bossi, F., Bernardi, S., Zauli, G., Secchiero, P. & Fabris, B. TRAIL Modulates the Immune System and Protects against the Development of Diabetes. J. Immunol. Res. 2015, e680749 (2015).","journal-title":"J. Immunol. Res."},{"key":"34068_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.isci.2018.12.037","volume":"12","author":"SP Cartland","year":"2019","unstructured":"Cartland, S. P. et al. TRAIL-Expressing Monocyte\/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis. iScience 12, 41\u201352 (2019).","journal-title":"iScience"},{"key":"34068_CR49","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/cmi.2017.2","volume":"15","author":"I-T Chyuan","year":"2018","unstructured":"Chyuan, I.-T., Tsai, H.-F., Liao, H.-J., Wu, C.-S. & Hsu, P.-N. An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis. Cell. Mol. Immunol. 15, 846\u2013857 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"34068_CR50","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/rheumatology\/key282","volume":"58","author":"A-K Pr\u00f6bstel","year":"2019","unstructured":"Pr\u00f6bstel, A.-K. et al. Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus. Rheumatol. Oxf. Engl. 58, 908\u2013913 (2019).","journal-title":"Rheumatol. Oxf. Engl."},{"key":"34068_CR51","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1161\/ATVBAHA.121.315928","volume":"41","author":"AM Pati\u00f1o-Trives","year":"2021","unstructured":"Pati\u00f1o-Trives, A. M. et al. Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation. Arterioscler. Thromb. Vasc. Biol. 41, 2417\u20132430 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"34068_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41371-020-0387-4","volume":"35","author":"RB Azevedo","year":"2021","unstructured":"Azevedo, R. B. et al. Covid-19 and the cardiovascular system: a comprehensive review. J. Hum. Hypertens. 35, 4\u201311 (2021).","journal-title":"J. Hum. Hypertens."},{"key":"34068_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15342-5","volume":"11","author":"FJ Ryan","year":"2020","unstructured":"Ryan, F. J. et al. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease. Nat. Commun. 11, 1512 (2020).","journal-title":"Nat. Commun."},{"key":"34068_CR54","doi-asserted-by":"publisher","first-page":"e03022","DOI":"10.1128\/mBio.03022-20","volume":"12","author":"HS Kim","year":"2021","unstructured":"Kim, H. S. Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity? mBio 12, e03022\u201320 (2021).","journal-title":"mBio"},{"key":"34068_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02212-0","volume":"20","author":"Z Sun","year":"2022","unstructured":"Sun, Z. et al. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med. 20, 24 (2022).","journal-title":"BMC Med."},{"key":"34068_CR56","doi-asserted-by":"publisher","first-page":"eabc7191","DOI":"10.1126\/sciimmunol.abc7191","volume":"5","author":"A-K Pr\u00f6bstel","year":"2020","unstructured":"Pr\u00f6bstel, A.-K. et al. Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis. Sci. Immunol. 5, eabc7191 (2020).","journal-title":"Sci. Immunol."},{"key":"34068_CR57","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2018.11.035","volume":"176","author":"OL Rojas","year":"2019","unstructured":"Rojas, O. L. et al. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10. Cell 176, 610\u2013624.e18 (2019).","journal-title":"Cell"},{"key":"34068_CR58","doi-asserted-by":"crossref","unstructured":"Kuchroo, V. K. et. al. Dysregulation of immune homeostasis in autoimmune diseases. Nat Med. 18, 42\u20137 (2012).","DOI":"10.1038\/nm.2621"},{"key":"34068_CR59","doi-asserted-by":"publisher","first-page":"e01381","DOI":"10.1128\/JCM.01381-21","volume":"59","author":"K Leuzinger","year":"2021","unstructured":"Leuzinger, K. et al. Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection. J. Clin. Microbiol. 59, e01381\u201321 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"34068_CR60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaut.2015.03.005","volume":"60","author":"J Wen","year":"2015","unstructured":"Wen, J. et al. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL\/lpr mice. J. Autoimmun. 60, 40\u201350 (2015).","journal-title":"J. Autoimmun."},{"key":"34068_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-9","volume":"10","author":"D Stephan","year":"2013","unstructured":"Stephan, D. et al. TWEAK\/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier. J. Neuroinflammation 10, 9 (2013).","journal-title":"J. Neuroinflammation"},{"key":"34068_CR62","doi-asserted-by":"publisher","unstructured":"Wood, H. VEGFA mediates blood-brain barrier disruption in Parkinson disease. Nat. Rev. Neurol. https:\/\/doi.org\/10.1038\/s41582-021-00594-6 (2021).","DOI":"10.1038\/s41582-021-00594-6"},{"key":"34068_CR63","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/JCI9369","volume":"106","author":"ZG Zhang","year":"2000","unstructured":"Zhang, Z. G. et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Investig. 106, 829\u2013838 (2000).","journal-title":"J. Clin. Investig."},{"key":"34068_CR64","doi-asserted-by":"publisher","first-page":"e2033012","DOI":"10.1001\/jamanetworkopen.2020.33012","volume":"4","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia. JAMA Netw. Open 4, e2033012 (2021).","journal-title":"JAMA Netw. Open"},{"key":"34068_CR65","doi-asserted-by":"publisher","first-page":"e23993","DOI":"10.4161\/tisb.23993","volume":"1","author":"S-Y Kook","year":"2013","unstructured":"Kook, S.-Y., Seok Hong, H., Moon, M. & Mook-Jung, I. Disruption of blood-brain barrier in Alzheimer disease pathogenesis. Tissue Barriers 1, e23993 (2013).","journal-title":"Tissue Barriers"},{"key":"34068_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1545-x","volume":"16","author":"AB DePaula-Silva","year":"2019","unstructured":"DePaula-Silva, A. B. et al. Differential transcriptional profiles identify microglial- and macrophage-specific gene markers expressed during virus-induced neuroinflammation. J. Neuroinflammation 16, 152 (2019).","journal-title":"J. Neuroinflammation"},{"key":"34068_CR67","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374\u20131377 (2003).","journal-title":"Science"},{"key":"34068_CR68","doi-asserted-by":"crossref","unstructured":"Gwo, C.-Y., Zhu, D. C. & Zhang, R. Brain White Matter Hyperintensity Lesion Characterization in T2 Fluid-Attenuated Inversion Recovery Magnetic Resonance Images: Shape, Texture, and Potential Growth. Front. Neurosci. 13, 353 (2019).","DOI":"10.3389\/fnins.2019.00353"},{"key":"34068_CR69","doi-asserted-by":"crossref","unstructured":"Nalugo, M., Schulte, L. J., Masood, M. F. & Zayed, M. A. Microvascular Angiopathic Consequences of COVID-19. Front. Cardiovasc. Med. 8, 636843 (2021).","DOI":"10.3389\/fcvm.2021.636843"},{"key":"34068_CR70","doi-asserted-by":"publisher","first-page":"E1036","DOI":"10.1152\/ajpendo.00001.2019","volume":"316","author":"W Czaja","year":"2019","unstructured":"Czaja, W. et al. Myostatin regulates pituitary development and hepatic IGF1. Am. J. Physiol. Endocrinol. Metab. 316, E1036\u2013E1049 (2019).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"34068_CR71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jchemneu.2018.10.001","volume":"94","author":"Y Hayashi","year":"2018","unstructured":"Hayashi, Y. et al. Myostatin expression in the adult rat central nervous system. J. Chem. Neuroanat. 94, 125\u2013138 (2018).","journal-title":"J. Chem. Neuroanat."},{"key":"34068_CR72","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Casta\u00f1eda, A. et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell S0092867422007139 https:\/\/doi.org\/10.1016\/j.cell.2022.06.008 (2022).","DOI":"10.1016\/j.cell.2022.06.008"},{"key":"34068_CR73","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"DR Phetsouphanh","year":"2022","unstructured":"Phetsouphanh, D. R. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nature Immunology 23, 210\u2013216 (2022).","journal-title":"Nature Immunology"},{"key":"34068_CR74","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.4049\/jimmunol.1500352","volume":"195","author":"SV Bardina","year":"2015","unstructured":"Bardina, S. V. et al. Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection. J. Immunol. 195, 4306\u20134318 (2015).","journal-title":"J. Immunol."},{"key":"34068_CR75","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1084\/jem.20071053","volume":"204","author":"EK Mathey","year":"2007","unstructured":"Mathey, E. K. et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J. Exp. Med. 204, 2363\u20132372 (2007).","journal-title":"J. Exp. Med."},{"key":"34068_CR76","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","volume":"77","author":"AK Pr\u00f6bstel","year":"2011","unstructured":"Pr\u00f6bstel, A. K. et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77, 580\u2013588 (2011).","journal-title":"Neurology"},{"key":"34068_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0256-1","volume":"12","author":"A-K Pr\u00f6bstel","year":"2015","unstructured":"Pr\u00f6bstel, A.-K. et al. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J. Neuroinflammation 12, 46 (2015).","journal-title":"J. Neuroinflammation"},{"key":"34068_CR78","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.neuroimage.2010.12.049","volume":"55","author":"J Ashburner","year":"2011","unstructured":"Ashburner, J. & Friston, K. J. Diffeomorphic registration using geodesic shooting and Gauss-Newton optimisation. NeuroImage 55, 954\u2013967 (2011).","journal-title":"NeuroImage"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34068-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34068-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34068-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:03:21Z","timestamp":1668189801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34068-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34068"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34068-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1385593\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2022.02.18.22271039","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"22 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.J. has received speaker honoraria or unrestricted grants from Biogen Idec and Novartis and has served as an advisor for Alexion, Biogen, Bristol Myers Squibb, Celgene, Janssen-Cilag, Neuway, Merck, Novartis, Roche and Sanofi Genzyme; none of these are related to this study. G.H. has equity in and is a co-founder of Incephalo Inc. A-K.P. has received speaker honoraria or research\/travel support from Roche and Biogen all used for research. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6777"}}